Alzheimer’s Disease/Dementia News

Patients with a higher household income received a dementia diagnosis earlier than individuals with a lower household income, indicating a “social inequality” in dementia evaluations, according to findings published in JAMA Network Open.

Late last year, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee met to discuss a Biologics License Application for aducanumab, an anti-amyloid antibody in development for Alzheimer’s disease.

Tamoxifen and steroidal aromatase inhibitor use among women with breast cancer was associated with a significantly lower risk for Alzheimer’s disease, a retrospective cohort study showed.

Entorhinal hypometabolism identified on fluorodeoxyglucose PET scans served as a “strong and independent predictor” of future cognitive decline in preclinical Alzheimer’s disease, according to findings from a prospective cohort study.

Decreased kidney function, as well as a sharper decline in kidney function, correlated with the development of dementia in older adults, according to results from a 5-year study of a health care use cohort published in Neurology.

Following a Mediterranean diet protected against memory decline and mediotemporal atrophy, according to a study published in Neurology.

Healio Psychiatry has compiled a list of its five most-viewed stories in April.

Onset of type 2 diabetes at younger ages appeared to play a role in the risk for dementia, according to results from a longitudinal cohort study published in JAMA.

Benzoate treatment appeared to improve cognitive function among women with later-phase dementia, according to results of a secondary analysis of a randomized clinical trial published in JAMA Network Open.

National Minority Health Month originated in 1915 with the establishment of National Negro Health Week by educator Booker T. Washington.